Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Protection certificate |
| Status | ST | Not pending/lapsed |
21 | DE file number | DAKZ | 12 2013 000 093.7 |
| Use | VZ | Medicinal products |
95 | Product name | TIEZ | Kombination umfassend Aliskiren oder ein pharmazeutisch akzeptables Salz davon und Amlodipin oder ein pharmazeutisch akzeptables Salz davon |
54 | Title of basic patent | TIGZ | Synergistische Kombinationen enthaltend einen Renininhibitor für Kardiovaskulären Erkrankungen |
51 | IPC main class | ICM (ICMV) | A61K 31/165 (2006.01) |
51 | IPC secondary class(es) | ICS (ICSV) | A61P 9/00 (2006.01), A61K 31/4422 (2006.01) |
94 | Start of term of protection | LB | Nov 16, 2021 |
22 | DE application date | DAT | Nov 25, 2013 |
| Date of publication of application for a certificate | OT | Jan 30, 2014 |
71/73 | Applicant/owner | INH | Novartis AG, Lichtstr. 35, 4056 Basel, CH |
74 | Representative | VTR | Henkel, Breuer & Partner, 80333 München, DE |
| Address for service | | Patentanwälte Henkel, Breuer & Partner, 80333 München, DE |
| Patent division in charge | | 42 |
68 | DE file number of basic patent | GAKZ | 601 48 143.7 |
68 | EP file number of basic patent | GEAKZ | 08 00 2401.1 |
43 | Date of first publication | EVT | Jan 30, 2014 |
92 92 92
| Domestic authorisation | GIS GIN GIT
| Europäische Kommission EU/1/11/686/001 - 056 2011-04-14
|
93 93 93 93
| EU authorisation | GES GEC GEN GET
| Europäische Kommission EU EU/1/11/686/001 - 056 2011-04-14
|
| Date of the first transfer into DPMAregister | EREGT | Jan 30, 2014 |
| Date of the (most recent) update in DPMAregister | REGT | Aug 9, 2024 (Show all update days)(Hide all update days)- Aug 9, 2024
- St.36: changed (technical change)
- Jan 13, 2022; Jul 16, 2019; Oct 21, 2017; Dec 3, 2016; Jan 21, 2016; Dec 16, 2015; Oct 13, 2015; Aug 27, 2015; Jul 11, 2015; Jul 6, 2014; May 4, 2014; Mar 2, 2014
- Historical data not available for this/these date(s)
- Jan 30, 2014
- Date of the first transfer into DPMAregister
|